ASCO 2022 Conference Coverage
Video Player is loading.
10 seconds
Playback speed
ASCO 2022 on SWOG S2012: Randomized Phase II/III Trial of 1L Platinum/Etoposide +/- Atezo in Poorly Differentiated Extrapulmonary Small Cell Neuroendocrine Carcinomas
By
ASCO 2022 Conference Coverage
FEATURING
David Zhen
By
ASCO 2022 Conference Coverage
FEATURING
David Zhen
Comments 0
Login to view comments.
Click here to Login
